Clinical Trials Browser

fosaprepitant × Genitourinary × Clear all

NCT01874119 2018-06-07

HDIL2/Emend

Phase 2 Terminated

13 enrolled 7 charts

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma, Vomiting

NCT01736917 2016-05-25

Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors

Phase 2 Completed

65 enrolled 14 charts

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms, Vomiting